Sanara MedTech stock holds near its 52-week high

Published on 09/20/2026 at 17:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanara MedTech stock closed at USD 35.07 on September 18, 2026, after MarketBeat listed a USD 35.00 consensus target. The stock trades far above its USD 16.05 low.

SMTI, US80007P1057, Illustration mit AI erstellt.

Sanara MedTech stock (ISIN US80007P1057) closed at USD 35.07 on September 18, 2026, with a market capitalization of USD 322.29 million and a 52-week range of USD 16.05 to USD 35.27. The move leaves the shares close to the top of that band, while MarketBeat listed a consensus target of USD 35.00 on September 19, 2026.

Analysts keep the target tight

MarketBeat said on September 19, 2026, that Sanara MedTech carries a consensus rating of Reduce, based on 4 hold ratings and 1 sell rating, with an average score of 1.80 and a target of USD 35.00. That target sits only 0.2 percent below the September 18 close of USD 35.07.

The same MarketBeat snapshot put average volume at 262,944 shares and reported 271,136 shares traded in the latest session. For investors, the narrow gap between price and target matters more than the headline move itself.

Price sits at the top

MarketBeat also showed the stock at USD 35.07 on September 18, 2026, against a low of USD 16.05 and a high of USD 35.27. The shares therefore traded just USD 0.20 below the 52-week peak and more than 118 percent above the low.

That setup is consistent with a stock that has already priced in a lot of optimism. The next question is whether the current level can hold above the recent ceiling.

Sanara MedTech stock close

Sanara MedTech stock ended September 18, 2026, at USD 35.07 on Nasdaq. The market value was USD 322.29 million, and the latest quoted range still left only limited room above the last close.